Acquisition DealIf the GTCR deal is blocked, SRDX is entitled to a $50.2 million break-up fee, which could provide significant value.
Legal ProceedingsGTCR/SRDX attorneys cited recent wins by other companies, suggesting that the FTC's argument of a market dominated by two players might be an overstatement.
Product DevelopmentThe addition of the Pounce XL should only broaden and strengthen the company’s value proposition to physicians.